H.R. 4958: Grocery Reform And Safety Act
This bill, titled the Grocery Reform and Safety Act, proposes changes to the regulations concerning food substances that are classified as "generally recognized as safe" (GRAS). Here are the main points of the bill in layman's terms:
Changes to GRAS Regulations
The bill amends existing laws to clarify the definition and requirements around substances considered GRAS, which are food items or additives assumed to be safe by experts in the field without needing pre-market approval from the FDA.
New Notification Requirements
- Manufacturers intending to use a substance as GRAS must now notify the Food and Drug Administration (FDA) before they begin using it, especially if it’s a new use or a substance that was not previously marketed in food.
- They must include detailed information in their notification, such as:
- Identity and composition of the substance.
- Manufacturing process.
- Intended effects and safety evidence, including data on potential health impacts.
Safety Reassessments
Every three years, the FDA is required to reassess the safety of at least ten selected food substances or classes of substances that were previously considered GRAS. This reassessment will involve:
- Evaluating updated information on dietary exposure and cumulative health effects.
- Asking manufacturers to conduct and submit safety evaluations for substances under review.
Public Access and Input
The bill mandates that once a notification is accepted, the FDA must make all relevant information, including safety data and public comments, accessible on their website. There will be a public comment period lasting at least 60 days after the notification is made.
Consequences for Non-Compliance
If a manufacturer fails to comply with these new regulations, the FDA can revoke a previously granted status that recognized the substance as GRAS. Additionally, the bill establishes monetary penalties for violations of its provisions.
Funding and Resources
The bill authorizes the necessary funds to implement these new oversight and assessment procedures, ensuring that the FDA has the resources required to manage the increased workload effectively.
Definitions Clarified
The bill includes specific definitions for terms related to safety assessments, such as:
- Carcinogenic: A substance that can cause cancer.
- Cumulative Effects: The combined health effects of related substances.
- Developmental Toxicity: Adverse effects on development due to exposure to the substance.
Relevant Companies
None found.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
1 sponsor
Actions
2 actions
Date | Action |
---|---|
Aug. 12, 2025 | Introduced in House |
Aug. 12, 2025 | Referred to the House Committee on Energy and Commerce. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.